BRPI0908477A2 - sistema de distribuição de medicamento contendo estradiol - Google Patents

sistema de distribuição de medicamento contendo estradiol

Info

Publication number
BRPI0908477A2
BRPI0908477A2 BRPI0908477A BRPI0908477A BRPI0908477A2 BR PI0908477 A2 BRPI0908477 A2 BR PI0908477A2 BR PI0908477 A BRPI0908477 A BR PI0908477A BR PI0908477 A BRPI0908477 A BR PI0908477A BR PI0908477 A2 BRPI0908477 A2 BR PI0908477A2
Authority
BR
Brazil
Prior art keywords
estradiol
delivery system
drug delivery
containing drug
drug
Prior art date
Application number
BRPI0908477A
Other languages
English (en)
Inventor
Funke Adrian
Zurth Christian
Terebesi Ildikó
Diefenbach Konstanze
Schäfers Matthias
General Sascha
Alincic-Kunz Sofia
Holler Thomas
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39365963&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0908477(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0908477A2 publication Critical patent/BRPI0908477A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BRPI0908477A 2008-02-13 2009-02-05 sistema de distribuição de medicamento contendo estradiol BRPI0908477A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2830208P 2008-02-13 2008-02-13
EP08002633 2008-02-13
PCT/EP2009/051303 WO2009101021A2 (en) 2008-02-13 2009-02-05 Estradiol-containing drug delivery system

Publications (1)

Publication Number Publication Date
BRPI0908477A2 true BRPI0908477A2 (pt) 2018-03-27

Family

ID=39365963

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908477A BRPI0908477A2 (pt) 2008-02-13 2009-02-05 sistema de distribuição de medicamento contendo estradiol

Country Status (27)

Country Link
US (1) US20110097405A1 (pt)
EP (1) EP2249803A2 (pt)
JP (1) JP2011511823A (pt)
KR (1) KR20100125309A (pt)
CN (1) CN101945646A (pt)
AR (1) AR070375A1 (pt)
AU (1) AU2009214193A1 (pt)
BR (1) BRPI0908477A2 (pt)
CA (1) CA2714340A1 (pt)
CL (1) CL2009000326A1 (pt)
CO (1) CO6290633A2 (pt)
CR (1) CR11632A (pt)
DO (1) DOP2010000252A (pt)
EA (1) EA201001245A1 (pt)
EC (1) ECSP10010400A (pt)
IL (1) IL206640A0 (pt)
MA (1) MA32073B1 (pt)
MX (1) MX2010008940A (pt)
NZ (1) NZ586666A (pt)
PA (1) PA8816001A1 (pt)
PE (1) PE20091471A1 (pt)
TN (1) TN2010000302A1 (pt)
TW (1) TW200940095A (pt)
UA (1) UA102680C2 (pt)
UY (1) UY31660A1 (pt)
WO (1) WO2009101021A2 (pt)
ZA (1) ZA201006517B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101310710B1 (ko) * 2011-03-23 2013-09-27 한미약품 주식회사 오메가-3 지방산 에스테르 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 경구용 복합 조성물
GB201200062D0 (en) 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
US9822257B2 (en) 2012-07-23 2017-11-21 Crayola Llc Dissolvable films and methods of using the same
KR20200040286A (ko) * 2015-03-02 2020-04-17 코로나리콘셉츠 엘엘씨 Peg 대사산물 및 peg 분해 생성물 검정을 위한 화합물 및 방법

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
DK0641192T3 (da) * 1992-05-18 1998-03-02 Minnesota Mining & Mfg Anordning til transmucosal lægemiddelafgivelse
DE4426709A1 (de) * 1994-07-20 1996-01-25 Schering Ag Steroidale Sexualhormone enthaltende feste Arzneiformen
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
CA2522761C (en) * 1998-04-17 2010-07-06 Michael E. Kafrissen Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
EE200200589A (et) * 2000-04-12 2004-04-15 Schering Aktiengesellschaft 8ß-hüdrokarbüülasendatud östratrieenid kasutamiseks selektiivsete östrogeenidena
EP1216712A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Cyclodextrin-drospirenone inclusion complexes
US20030004145A1 (en) * 2001-05-16 2003-01-02 Leonard Thomas W. Treatment of conditions relating to hormone deficiencies by administration of progestins
ATE482692T1 (de) * 2001-07-27 2010-10-15 Astellas Pharma Inc Zusammensetzung enthaltend feine körner mit verzögerter freisetzung für in der mundhöhle schnell zerfallende tabletten
NZ534806A (en) * 2002-02-21 2006-05-26 Schering Ag Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin B12
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
WO2005004989A2 (en) * 2003-07-01 2005-01-20 Todd Maibach Film comprising therapeutic agents
US8153161B2 (en) * 2003-12-09 2012-04-10 Dainippon Sumitomo Pharma Co., Ltd. Medicament-containing particle and a solid preparation containing the particle
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
DE102004023984A1 (de) * 2004-05-14 2005-12-08 Hf Arzneimittelforschung Gmbh Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
DE102005015128B4 (de) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafer enthaltend Steroidhormone
WO2006127879A1 (en) * 2005-05-26 2006-11-30 Duramed Pharmaceuticals, Inc. Flexible solid dosage forms and methods of making and using the same
DE102005058569B4 (de) * 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
DE102005062270A1 (de) * 2005-12-24 2007-06-28 Bayer Technology Services Gmbh Geschmacksmaskierung von Pulvern
DE102006003512A1 (de) * 2006-01-24 2007-08-02 Bayer Schering Pharma Ag Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen
EP1867321A3 (en) * 2006-06-07 2008-11-19 Familplan Consulting Ltd. A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
DE102006027792A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antidepressiva-Kombinations-Wafer
US20080058272A1 (en) * 2006-08-29 2008-03-06 Juergen Becker Nonamer Peptides for Cancer Treatment

Also Published As

Publication number Publication date
WO2009101021A3 (en) 2009-12-30
CN101945646A (zh) 2011-01-12
EA201001245A1 (ru) 2011-04-29
CL2009000326A1 (es) 2010-07-19
AR070375A1 (es) 2010-03-31
TN2010000302A1 (en) 2011-11-11
EP2249803A2 (en) 2010-11-17
AU2009214193A1 (en) 2009-08-20
NZ586666A (en) 2012-04-27
DOP2010000252A (es) 2010-08-31
UA102680C2 (ru) 2013-08-12
ZA201006517B (en) 2014-02-26
TW200940095A (en) 2009-10-01
KR20100125309A (ko) 2010-11-30
UY31660A1 (es) 2009-09-30
CO6290633A2 (es) 2011-06-20
US20110097405A1 (en) 2011-04-28
CR11632A (es) 2010-10-05
PA8816001A1 (es) 2009-09-17
PE20091471A1 (es) 2009-10-25
CA2714340A1 (en) 2009-08-20
IL206640A0 (en) 2010-12-30
ECSP10010400A (es) 2010-09-30
MA32073B1 (fr) 2011-02-01
MX2010008940A (es) 2010-10-05
WO2009101021A2 (en) 2009-08-20
JP2011511823A (ja) 2011-04-14

Similar Documents

Publication Publication Date Title
BRPI0917030A2 (pt) sistema de liberação de fármaco contendo progestina
BRPI0913214A2 (pt) sistema de fornecimento de drogas transdérmico estabilizado
BRPI0819245A2 (pt) sistema de distribuição transdérmica
DK2398500T3 (da) Glutathion-baseret lægemiddelafgivelsessystem
DK2274030T4 (da) Lægemiddelafgivelsesanordning
DK2185220T3 (da) Anordning til lægemiddelfremføring
ATE531410T1 (de) Arzneimittelabgabevorrichtung
BRPI1007466A2 (pt) conjugado de insulina cristalina, formulação de liberação prolongada, e, sistema de distribuição de bomba
BR112013012818A2 (pt) módulo medicamentoso e sistema de administração de fármaco
BRPI1010279A2 (pt) dispositivo de distribuição de fármaco
DK2274032T3 (da) Anordning til medicinindgivelse
BRPI1013399A2 (pt) sistema de entrega de fármaco intervencional e métodos associados
BRPI1012730A2 (pt) dispositivo de distribuição de fármaco
BRPI0912144A2 (pt) configuração de sistema de infusão
BRPI0818129A2 (pt) Sistema de transporte e administração de medicamento seguro
DK2493532T3 (da) Lægemiddelfremføringsanordning
BRPI1014975A2 (pt) sistema de entrega de implante
DK2381988T3 (da) Medikamentadministrationsanordning
DK2355867T3 (da) Anordning til medikamentafgivelse
BRPI1010237A2 (pt) dispositivo de distribuição de fármaco
DK2296732T3 (da) Medikamentafgivelsesindretning
BRPI0920690A2 (pt) sistema de distribuição de stent restringível
DK2403569T3 (da) Lægemiddelafgivelsesanordning med tilbagetrækkelig nål
ZA201002014B (en) Drug delivery system
BRPI1007457A2 (pt) Conjungado, formulação de liberação prolongada, e, sistema de distribuição de bomba.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]